Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Subscribe to see Orionis Biosciences LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Orionis Biosciences LLC is a biotechnology company headquartered in United States. It has raised at least $79.5M across the 4 funding rounds on record. Its most recent funding round, Series B, raised $55M in October 2022. Xcout tracks 10 named people at Orionis Biosciences LLC, including Giulio Draetta (Chief Strategy Officer).
4 more named people on record for Orionis Biosciences LLC, with roles, board committees and tenure — see the full roster →
At least $79.5M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $55M | 2 named | |
| SEC Form D filing | $19.7M | — | |
| SEC Form D filing | $750,000 | — | |
| Series A | $4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Orionis Biosciences LLC's closest competitors — see the full list of competitors and alternatives →
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Bonito Biosciences is a life-science company headquartered in Waltham, Massachusetts, building a delivery ligand discovery platform that combines encoded libraries, functional live-cell selections, and AI.
Violet Therapeutics, Inc. is a therapeutics company headquartered in Cambridge, Massachusetts, utilizing novel proprietary platforms for drug development.
Minerva Biotechnologies Corp. is a biotechnology holding company based in Woburn, Massachusetts, engaged in drug pipelines and patent development.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.